Matches in Nanopublications for { ?s ?p "[Four single nucleotide polymorphisms comprising the major MYH9 E1 risk haplotype were tested for association with estimated glomerular filtration rate (eGFR) and urine albumin:creatinine ratio (ACR) in 2,903 HyperGEN participants (1,458 African Americans (AA) in 895 families and 1,445 European Americans (EA) in 859 families) to determine the role of MYH9 in subclinical nephropathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NP264858.RAjcaPmv-QhqPvh01GN4V_lJSYmy8ZaiIAmK61lIpxxy8130_assertion description "[Four single nucleotide polymorphisms comprising the major MYH9 E1 risk haplotype were tested for association with estimated glomerular filtration rate (eGFR) and urine albumin:creatinine ratio (ACR) in 2,903 HyperGEN participants (1,458 African Americans (AA) in 895 families and 1,445 European Americans (EA) in 859 families) to determine the role of MYH9 in subclinical nephropathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP264858.RAjcaPmv-QhqPvh01GN4V_lJSYmy8ZaiIAmK61lIpxxy8130_provenance.
- assertion description "[Four single nucleotide polymorphisms comprising the major MYH9 E1 risk haplotype were tested for association with estimated glomerular filtration rate (eGFR) and urine albumin:creatinine ratio (ACR) in 2,903 HyperGEN participants (1,458 African Americans (AA) in 895 families and 1,445 European Americans (EA) in 859 families) to determine the role of MYH9 in subclinical nephropathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP715307.RAby-D_temX0uJE512PgPndkFn-sBw7ktqrNjBxoUQrQQ130_assertion description "[Four single nucleotide polymorphisms comprising the major MYH9 E1 risk haplotype were tested for association with estimated glomerular filtration rate (eGFR) and urine albumin:creatinine ratio (ACR) in 2,903 HyperGEN participants (1,458 African Americans (AA) in 895 families and 1,445 European Americans (EA) in 859 families) to determine the role of MYH9 in subclinical nephropathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP715307.RAby-D_temX0uJE512PgPndkFn-sBw7ktqrNjBxoUQrQQ130_provenance.
- NP715309.RAZqQL54wnntml7wa0M4eCkpz6h9jD9gDHaRFSCXVrUWU130_assertion description "[Four single nucleotide polymorphisms comprising the major MYH9 E1 risk haplotype were tested for association with estimated glomerular filtration rate (eGFR) and urine albumin:creatinine ratio (ACR) in 2,903 HyperGEN participants (1,458 African Americans (AA) in 895 families and 1,445 European Americans (EA) in 859 families) to determine the role of MYH9 in subclinical nephropathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP715309.RAZqQL54wnntml7wa0M4eCkpz6h9jD9gDHaRFSCXVrUWU130_provenance.
- NP233506.RA464eNuYEE-h3fV_wk9aqL1viXxQtOeV4FtKDXnV-yto130_assertion description "[Four single nucleotide polymorphisms comprising the major MYH9 E1 risk haplotype were tested for association with estimated glomerular filtration rate (eGFR) and urine albumin:creatinine ratio (ACR) in 2,903 HyperGEN participants (1,458 African Americans (AA) in 895 families and 1,445 European Americans (EA) in 859 families) to determine the role of MYH9 in subclinical nephropathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP233506.RA464eNuYEE-h3fV_wk9aqL1viXxQtOeV4FtKDXnV-yto130_provenance.